24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination
The purpose of this study is to compare the short-term (8 week) mean 24-hour intraocular pressure control and safety of TravTim fixed combination given once in the evening with placebo once in the morning versus TravTim given once in the morning with placebo once in the evening in patients with open-angle glaucoma...
Brief Summary
Official Title: “24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination”
The purpose of this study is to compare the short-term (8 week) mean 24-hour intraocular pressure control and safety of TravTim fixed combination given once in the evening with placebo once in the morning versus TravTim given once in the morning with placebo once in the evening in patients with open-angle glaucoma.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment
- Study Primary Completion Date: January 2007
Intervention(s) in this Clinical Trial
- Drug: travoprost/timolol fixed combination
- Drug: placebo (artificial tears)
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- POAG
- Exfoliation syndrome
Exclusion Criteria:
- Advanced glaucoma
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 29 Years
Maximum Age for this Clinical Trial: 80 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Aristotle University Of Thessaloniki Other
Overall Clinical Trial Officials and Contacts
AGP Konstas, MD, PhD Principal Investigator Glaucoma Unit, A University Dept of Ophthalmology, AHEPA Hospital
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00331240
Study ID Number: A1457
ClinicalTrials.gov Identifier: NCT00331240
Health Authority: Greece: National Organization of Medicines
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00331240
